Stemmer SM
Stemmer SM
Rabin Medical Center
Geverifieerd e-mailadres voor post.tau.ac.il
Titel
Geciteerd door
Geciteerd door
Jaar
Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation
B Kaufman, R Shapira-Frommer, RK Schmutzler, MW Audeh, ...
Journal of clinical oncology 33 (3), 244, 2015
13142015
Ribociclib as first-line therapy for HR-positive, advanced breast cancer
GN Hortobagyi, SM Stemmer, HA Burris, YS Yap, GS Sonke, ...
New England journal of medicine 375 (18), 1738-1748, 2016
10222016
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
RL Coleman, AM Oza, D Lorusso, C Aghajanian, A Oaknin, A Dean, ...
The Lancet 390 (10106), 1949-1961, 2017
6942017
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer …
R Herrmann, G Bodoky, T Ruhstaller, B Glimelius, E Bajetta, J Schuller, ...
Journal of Clinical Oncology 25 (16), 2212-2217, 2007
6622007
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases
F Saad, JE Brown, C Van Poznak, T Ibrahim, SM Stemmer, AT Stopeck, ...
Annals of Oncology 23 (5), 1341-1347, 2012
6562012
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood …
EJ Shpall, RB Jones, SI Bearman, WA Franklin, PG Archer, T Curiel, ...
Journal of Clinical Oncology 12 (1), 28-36, 1994
4531994
Randomized phase II study of the anti–epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple …
J Baselga, P Gómez, R Greil, S Braga, MA Climent, AM Wardley, ...
Journal of clinical oncology 31 (20), 2586, 2013
3462013
The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy
R Scherz-Shouval, S Santagata, ML Mendillo, LM Sholl, I Ben-Aharon, ...
Cell 158 (3), 564-578, 2014
2562014
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced …
GN Hortobagyi, SM Stemmer, HA Burris, YS Yap, GS Sonke, ...
Annals of Oncology 29 (7), 1541-1547, 2018
2542018
Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials
L Bonilla, I Ben-Aharon, L Vidal, A Gafter-Gvili, L Leibovici, SM Stemmer
Journal of the National Cancer Institute 102 (24), 1845-1854, 2010
2142010
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE …
HS Wasan, P Gibbs, NK Sharma, J Taieb, V Heinemann, J Ricke, ...
The Lancet Oncology 18 (9), 1159-1171, 2017
1882017
Interventions for alleviating cancer-related dyspnea: a systematic review
I Ben-Aharon, A Gafter-Gvili, M Paul, L Leibovici, SM Stemmer
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2008
1812008
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy
SM Domchek, C Aghajanian, R Shapira-Frommer, RK Schmutzler, ...
Gynecologic oncology 140 (2), 199-203, 2016
1742016
Actual and preferred place of death of home-dwelling patients in four European countries: making sense of quality indicators
ML De Roo, G Miccinesi, BD Onwuteaka-Philipsen, N Van Den Noortgate, ...
PloS one 9 (4), e93762, 2014
1342014
The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-κB signal transduction pathways
S Bar-Yehuda, SM Stemmer, L Madi, D Castel, A Ochaion, S Cohen, ...
International journal of oncology 33 (2), 287-295, 2008
1342008
White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy.
MS Brown, SM Stemmer, JH Simon, JC Stears, RB Jones, PJ Cagnoni, ...
American Journal of Neuroradiology 19 (2), 217-221, 1998
1311998
Doxorubicin-induced ovarian toxicity
I Ben-Aharon, H Bar-Joseph, G Tzarfaty, L Kuchinsky, S Rizel, ...
Reproductive Biology and Endocrinology 8 (1), 1-7, 2010
1302010
Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter …
J Bernhard, D Dietrich, W Scheithauer, D Gerber, G Bodoky, T Ruhstaller, ...
Journal of clinical oncology 26 (22), 3695-3701, 2008
1262008
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
M Schuler, JCH Yang, K Park, JH Kim, J Bennouna, YM Chen, C Chouaid, ...
Annals of Oncology 27 (3), 417-423, 2016
1252016
A prospective cohort study of the effects of adjuvant breast cancer chemotherapy on taste function, food liking, appetite and associated nutritional outcomes
A Boltong, S Aranda, R Keast, R Wynne, PA Francis, J Chirgwin, K Gough
PloS one 9 (7), e103512, 2014
1062014
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20